Analysts expect that Colgate-Palmolive Company (NYSE:CL) will post $0.75 earnings per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Colgate-Palmolive’s earnings, with the highest EPS estimate coming in at $0.76 and the lowest estimate coming in at $0.74. Colgate-Palmolive also reported earnings per share of $0.75 during the same quarter last year. The firm is scheduled to report its next quarterly earnings results on Friday, January 26th.

On average, analysts expect that Colgate-Palmolive will report full-year earnings of $2.88 per share for the current fiscal year, with EPS estimates ranging from $2.86 to $2.95. For the next financial year, analysts expect that the company will post earnings of $3.09 per share, with EPS estimates ranging from $3.02 to $3.15. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.73 earnings per share.

A number of brokerages have recently commented on CL. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Wednesday. Citigroup Inc. lowered their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. Jefferies Group LLC lowered their price target on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a report on Monday, October 30th. Finally, Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $76.67.

ILLEGAL ACTIVITY NOTICE: “Analysts Expect Colgate-Palmolive Company (CL) Will Post Earnings of $0.75 Per Share” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/11/analysts-expect-colgate-palmolive-company-cl-will-post-earnings-of-0-75-per-share.html.

Shares of Colgate-Palmolive (NYSE:CL) opened at $73.21 on Friday. The company has a market cap of $64,100.00, a PE ratio of 25.53, a PEG ratio of 3.36 and a beta of 0.80. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.

In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the transaction, the insider now directly owns 53,173 shares in the company, valued at $3,799,210.85. The disclosure for this sale can be found here. Insiders own 1.02% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Pacer Advisors Inc. raised its stake in shares of Colgate-Palmolive by 8.4% during the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after purchasing an additional 1,566 shares during the period. Alliancebernstein L.P. raised its stake in shares of Colgate-Palmolive by 4.2% during the first quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares during the period. Israel Discount Bank of New York purchased a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $1,349,000. Principal Financial Group Inc. raised its stake in shares of Colgate-Palmolive by 0.6% during the first quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after purchasing an additional 7,905 shares during the period. Finally, Personal Capital Advisors Corp raised its stake in shares of Colgate-Palmolive by 5.8% during the second quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after purchasing an additional 21,456 shares during the period. 73.63% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.